Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Diamondback Energy Inc (FANG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Diamondback Energy Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.68 (market cap $4.59B), while Diamondback Energy Inc trades at $193.08 (market cap $53.67B). The key difference: Diamondback Energy Inc is far larger — about 11.7× Definium Therapeutics Inc. Common Shares's market cap, and Diamondback Energy Inc pays a 2.3% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Diamondback Energy Inc for 69 Days on average.
| DFTX | FANG | |
|---|---|---|
Market Cap | $4.59B | $53.67B |
Volume | 2,103,937 | 2,250,644 |
Sector | Health | Energy |
52-Week High | $48.45 | $213.69 |
52-Week Low | $10.68 | $137.29 |
Typical Hold Time | 0 Days | 69 Days |
Enterprise Value | $3.55B | $65.83B |
Dividend Yield | — | 2.3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Diamondback Energy (FANG) trades at $184.38, down 0.32% on the day, with a bearish technical signal from moving averages. The company shows strong revenue growth from $14.93B in 2025 to projected $17.0B in 2026, though net margins have compressed. Recent Q2 2026 earnings beat expectations at $6.48 EPS versus $6.08 expected. Analyst sentiment remains overwhelmingly positive with 90.57% buy ratings and a $231.77 consensus price target, representing 26% upside from current levels.
FANG presents a compelling growth story with robust cash flow generation and strategic positioning in the Permian Basin. Key risks include oil price volatility and insider selling activity. The stock's current valuation at 36.51 P/E appears reasonable given growth prospects, while technical support at $182 provides a near-term floor. Institutional accumulation and strong analyst support suggest confidence in long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Diamondback Energy Inc
Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2021, the company reported net proven reserves of 1.8 billion barrels of oil equivalent. Net production averaged about 375,000 barrels per day in 2021, at a ratio of 60% oil, 20% natural gas liquids, and 20% natural gas.
Read more on FANG →
